Skip to main content Back to Top
Advertisement

5/30/2019

Potassium Chloride Injection

Reason for the Shortage

    • Baxter has potassium chloride injection available.
    • Fresenius Kabi has potassium chloride injection available.
    • Pfizer has potassium chloride injection available. Pfizer discontinued 2 mEq/mL 250 mL bottles in mid-2018.
    • ICU Medical has potassium chloride injection available.
    • ICU Medical discontinued potassium chloride 10 mEq/500 mL in 5% dextrose and 0.225% sodium chloride in 2018.

Available Products

    • Potassium chloride injection, BBraun, 2 mEq/mL, 250 mL bulk package 1 count, NDC 00264-1940-20
    • Potassium chloride injection, Fresenius Kabi, 2 mEq/mL, 10 mL vial, 25 count, NDC 63323-0965-10
    • Potassium chloride injection, Fresenius Kabi, 2 mEq/mL, 20 mL vial, 25 count, NDC 63323-0965-20
    • Potassium chloride injection, Fresenius Kabi, 2 mEq/mL, 30 mL vial, 25 count, NDC 63323-0967-30
    • Potassium chloride injection, Fresenius Kabi, 2 mEq/mL, 5 mL vial, 25 count, NDC 63323-0965-05
    • Potassium chloride injection, Pfizer, 2 mEq/mL, 10 mL vial, 25 count, NDC 00409-6651-06
    • Potassium chloride injection, Pfizer, 2 mEq/mL, 20 mL vial, 25 count, NDC 00409-6653-05
    • Potassium chloride injection, Pfizer, 2 mEq/mL, 5 mL vial, 25 count, NDC 00409-6635-01
    • Potassium chloride injection, Baxter, 20 mEq/L, 5% dextrose 14 count, NDC 00338-0683-04
    • Potassium chloride injection, ICU Medical, 20 mEq/L, 5% dextrose 12 count, NDC 00409-7905-09
    • Potassium chloride injection, Baxter, 20 mEq/L, 5% dextrose and lactated ringers 14 count, NDC 00338-0811-04
    • Potassium chloride injection, ICU Medical, 20 mEq/L, 5% dextrose and lactated ringers 12 count, NDC 00409-7111-09
    • Potassium chloride injection, Baxter, 10 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count, NDC 00338-0669-04
    • Potassium chloride injection, Baxter, 20 mEq/500 mL, 5% dextrose and 0.2% sodium chloride 14 count, NDC 00338-0663-03
    • Potassium chloride injection, Baxter, 20 mEq/500 mL, 5% dextrose and 0.45% sodium chloride 24 count, NDC 00338-0671-03
    • Potassium chloride injection, Baxter, 20 mEq/L, 5% dextrose and 0.2% sodium chloride 14 count, NDC 00338-0663-04
    • Potassium chloride injection, Baxter, 20 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count, NDC 00338-0671-04
    • Potassium chloride injection, Baxter, 20 mEq/L, 5% dextrose and 0.9% sodium chloride 14 count, NDC 00338-0803-04
    • Potassium chloride injection, Baxter, 30 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count, NDC 00338-0673-04
    • Potassium chloride injection, Baxter, 40 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count, NDC 00338-0675-04
    • Potassium chloride injection, Baxter, 40 mEq/L, 5% dextrose and 0.9% sodium chloride 14 count, NDC 00338-0807-04
    • Potassium chloride injection, ICU Medical, 10 mEq/500 mL, 5% dextrose and 0.45% sodium chloride 24 count, NDC 00409-7902-03
    • Potassium chloride injection, ICU Medical, 10 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count, NDC 00409-7993-09
    • Potassium chloride injection, ICU Medical, 20 mEq/L, 5% dextrose and 0.225% sodium chloride 12 count, NDC 00409-7901-09
    • Potassium chloride injection, ICU Medical, 20 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count, NDC 00409-7902-09
    • Potassium chloride injection, ICU Medical, 20 mEq/L, 5% dextrose and 0.9% sodium chloride 12 count, NDC 00409-7107-09
    • Potassium chloride injection, ICU Medical, 30 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count, NDC 00409-7903-09
    • Potassium chloride injection, ICU Medical, 40 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count, NDC 00409-7904-09
    • Potassium chloride injection, ICU Medical, 40 mEq/L, 5% dextrose and 0.9% sodium chloride 12 count, NDC 00409-7109-09
    • Potassium chloride injection, Baxter, 20 mEq/L, 0.45% sodium chloride 14 count, NDC 00338-0704-34
    • Potassium chloride injection, Baxter, 20 mEq/L, 0.9% sodium chloride 14 count, NDC 00338-0691-04
    • Potassium chloride injection, Baxter, 40 mEq/L, 0.9% sodium chloride 14 count, NDC 00338-0695-04
    • Potassium chloride injection, ICU Medical, 20 mEq/L, 0.45% sodium chloride 12 count, NDC 00409-9257-39
    • Potassium chloride injection, ICU Medical, 20 mEq/L, 0.9% sodium chloride 12 count, NDC 00409-7115-09
    • Potassium chloride injection, ICU Medical, 40 mEq/L, 0.9% sodium chloride 12 count, NDC 00409-7116-09
    • Potassium chloride injection, Baxter, 10 mEq/100 mL, sterile water 24 count, NDC 00338-0709-48
    • Potassium chloride injection, Baxter, 10 mEq/50 mL, sterile water 24 count, NDC 00338-0705-41
    • Potassium chloride injection, Baxter, 20 mEq/100 mL, sterile water 24 count, NDC 00338-0705-48
    • Potassium chloride injection, Baxter, 20 mEq/50 mL, sterile water 24 count, NDC 00338-0703-41
    • Potassium chloride injection, Baxter, 40 mEq/100 mL, sterile water 24 count, NDC 00338-0703-48
    • Potassium chloride injection, ICU Medical, 10 mEq/100 mL, sterile water 24 count, NDC 00409-7074-26
    • Potassium chloride injection, ICU Medical, 10 mEq/50 mL, sterile water 24 count, NDC 00409-7075-14
    • Potassium chloride injection, ICU Medical, 20 mEq/100 mL, sterile water 24 count, NDC 00409-7075-26
    • Potassium chloride injection, ICU Medical, 20 mEq/50 mL, sterile water 24 count, NDC 00409-7077-14
    • Potassium chloride injection, ICU Medical, 40 mEq/100 mL, sterile water 24 count, NDC 00409-7077-26

Estimated Resupply Dates

    • All marketed presentations are available.

Safety

    • During this shortage, use oral therapy whenever possible to reserve remaining IV supplies. Compounding potassium-containing products poses significant safety risks. Consider oral therapy for patients with enteral or oral access and patients with potassium concentrations higher than 2.8 mmol/L.

Alternative Agents & Management

    • To help alleviate the potassium chloride shortage, Athenex is coordinating with FDA to temporarily import potassium chloride 2 mEq/mL concentrate for injection 10 mL ampules in 10 count. This is manufactured and marketed in Italy by Industria Farmaceutica Galenica Senese S.r.l. (Galenica). Additional information can be found at the FDA shortage site https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Potassium%20Chloride%20Injection&st=c&tab=tabs-1# and at the Dear Healthcare Professional Letter https://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/ucm615370.pdf
    • Laboratoire Aguettant (Aguettant) is coordinating with FDA to temporarily import Potassium Chloride Proamp 0.15 g/mL (equivalent to 2 mEq/mL) concentrate for injection 10 mL ampules in 50 count to help alleviate the potassium chloride shortage. This product is distributed by La Jolla Pharmaceuticals. Additional information can be found at the FDA shortage site https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Potassium%20Chloride%20Injection&st=c&tab=tabs-1# and at the Dear Healthcare Professional Letter https://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM616862.pdf

Updated

Updated May 30, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 28, 2012 by Jane Chandramouli, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT